Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

alpha-Glucosidase deficiency (Pompe's disease).

J M Tager1, R P Oude Elferink, A Reuser

  • 1Laboratory of Biochemistry, University of Amsterdam, The Netherlands.

Enzyme
|January 1, 1987
PubMed
Summary

Pompe's disease involves alpha-glucosidase deficiency, but varying defect types can cause diverse clinical symptoms. Understanding these defects is crucial for Pompe's disease research.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterization of different oligomeric forms of CRISP2 in the perinuclear theca versus the fibrous tail structures of boar spermatozoa†.

Biology of reproduction·2021
Same author

Transcriptional and epigenetic profiling of nutrient-deprived cells to identify novel regulators of autophagy.

Autophagy·2018
Same author

Rupture of the middle cerebral artery aneurysm as a presenting symptom of late-onset Pompe disease in an adult with a novel GAA gene mutation.

Acta neurologica Belgica·2013
Same author

Rapid separation of particulate components and soluble cytoplasm of isolated rat-liver cells.

Biochimica et biophysica acta·2009
Same author

Molecular and functional characterization of eight novel GAA mutations in Italian infants with Pompe disease.

Human mutation·2008
Same author

Methods for a prompt and reliable laboratory diagnosis of Pompe disease: report from an international consensus meeting.

Molecular genetics and metabolism·2007

Area of Science:

  • Biochemistry
  • Genetics
  • Metabolic Disorders

Background:

  • Pompe's disease is characterized by deficient alpha-glucosidase activity (less than 30% of control levels).
  • The severity of clinical symptoms in Pompe's disease does not consistently correlate with the degree of alpha-glucosidase deficiency.

Purpose of the Study:

  • To investigate the various molecular defects leading to alpha-glucosidase deficiency in Pompe's disease.
  • To explore the relationship between different types of alpha-glucosidase defects and the resulting clinical phenotypes.

Main Methods:

  • Analysis of molecular defects including enzyme synthesis, mRNA levels, precursor processing, and protein stability.
  • Correlation of identified defects with clinical manifestations of Pompe's disease.

Related Experiment Videos

Main Results:

  • Defects identified include synthesis of inactive enzyme, absent mRNA, reduced precursor synthesis, impaired phosphorylation, abnormal precursor conversion, and unstable precursor formation.
  • A single type of defect can manifest in different clinical phenotypes, indicating complex disease mechanisms.

Conclusions:

  • Multiple molecular defects can cause alpha-glucosidase deficiency in Pompe's disease.
  • The diverse range of defects and their varied clinical impact highlight the complexity of Pompe's disease pathogenesis.
  • Alpha-glucosidase precursor is found in the brush border of small intestine and kidney epithelial cells and is secreted in urine.